Paper Details

  1. Home
  2. Paper Details

Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder.

Author: HangEvelyn, MillerAmber R, NordahlThomas E, SchafferCharles B, SchafferLinda C

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Insomnia is a common problem in patients with bipolar disorder. Nonbenzodiazepine hypnotics (NBZHs) are often used to treat insomnia in these patients, but there is no specific FDA indication for their use.
Paper Details　
Original Abstract of the Article :
Insomnia in patients with bipolar disorder (BD) can cause distress, daytime dysfunction, cognitive impairment, worsening of hypomanic/manic symptoms and increased suicide risk. Physicians often prescribe hypnotics for BD patients with insomnia although no hypnotic has a specific FDA indication for t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jad.2010.07.018

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Insomnia: Treatment Options for Bipolar Disorder

The [treatment of insomnia] in patients with [bipolar disorder (BD)] presents a unique challenge. This research delves into the use of [nonbenzodiazepine hypnotics (NBZHs)] in this population. The study explores the patterns of use, efficacy, and safety of five NBZHs in a large group of outpatients with BD. The authors acknowledge the lack of specific FDA indication for the use of hypnotics in BD patients with insomnia, highlighting the need for further research to determine optimal treatment strategies.

Illuminating the Path: A New Approach to Treating Insomnia in Bipolar Disorder

The findings of this research shed light on the potential benefits and drawbacks of NBZHs in treating insomnia in BD patients. The study's exploration of efficacy and safety provides valuable insights for clinicians seeking to optimize treatment outcomes for this challenging patient population. The need for further research to guide the use of hypnotics in BD patients is underscored.

The Journey Towards Better Sleep: A Guide for Bipolar Patients

The study's exploration of nonbenzodiazepine hypnotics offers valuable insights for individuals with bipolar disorder seeking effective treatment for insomnia. The findings emphasize the importance of seeking guidance from healthcare professionals when navigating the complex landscape of sleep disorders and mental health conditions.

Dr.Camel's Conclusion

The study's exploration of nonbenzodiazepine hypnotics provides a vital roadmap for navigating the challenges of insomnia in bipolar disorder. The findings underscore the importance of personalized treatment approaches and the need for ongoing research to optimize treatment outcomes for this complex patient population.

Date :
  1. Date Completed 2011-04-25
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

20701978

DOI: Digital Object Identifier

10.1016/j.jad.2010.07.018

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.